Log In
Print
BCIQ
Print
Print this Print this
 

eritoran (E5564)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionSynthetic lipid A analog that blocks toll-like receptor 4 (TLR4) activation
Molecular Target Toll-like receptor 4 (TLR4)
Mechanism of ActionUndisclosed
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationSepsis
Indication DetailsTreat severe sepsis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today